An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (/) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
Overview
Authors
Affiliations
Purpose: To examine the physicochemical properties of five preservative-free (PF) 0.005% latanoprost ophthalmic products; Monoprost, Latanest, Gaap Ofteno, Xalmono, and Xaloptic Free. Furthermore, the study investigated the mucin production and cell survival of primary cultured human conjunctival goblet cells when treated with PF eye drops.
Method: The pH value, osmolality, and surface tension were examined. Cell survival was analyzed using lactate dehydrogenase and tetrazolium dye colorimetric assays. Mucin production was analyzed with immunohistochemical staining.
Results: Monoprost (pH value 6.84 ± 0.032) had a pH value closest to the pH value of tear fluid (pH value 7.4-7.6), whereas Gaap Ofteno (pH value 6.34 ± 0.004) and Latanest (pH value 6.33 ± 0.003) had the lowest pH values. Gaap Ofteno (325.9 ± 2.9 mosmol/kg) showed iso-osmolar probabilities, whereas the other products were hypo-osmolar. Gaap Ofteno (60.31 ± 0.35 mN/m) had a higher surface tension compared to the tear fluid (40 to 46 mN/m), as described in the literature. No significant differences in goblet cell survival or mucin release were observed between the treatments and control.
Conclusion: Significant differences in pH value, osmolality, and surface tension were observed. However, this did not affect the viability of the goblet cells or the release of mucin. Clinical studies are required to evaluate the long-term effects of use on efficacy and safety.
Brugnera M, Vicario-de-la-Torre M, Gonzalez-Cela Casamayor M, Lopez-Cano J, Bravo-Osuna I, Huete-Toral F Drug Deliv Transl Res. 2024; 14(10):2804-2822.
PMID: 38602615 PMC: 11385046. DOI: 10.1007/s13346-024-01584-z.
Cvenkel B, Kolko M J Clin Med. 2023; 12(17).
PMID: 37685561 PMC: 10487839. DOI: 10.3390/jcm12175494.
Local production of eye drops in the hospital or pharmacy setting: considerations and safety tips.
Mohamed-Ahmed A, Kuguminkiriza D Community Eye Health. 2023; 36(118):17-18.
PMID: 37273803 PMC: 10236422.
Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review.
Cvenkel B, Kolko M J Clin Med. 2023; 12(1).
PMID: 36614952 PMC: 9821329. DOI: 10.3390/jcm12010151.